A detailed history of Lord, Abbett & Co. LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 80,035 shares of TMO stock, worth $48.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
80,035
Previous 78,247 2.29%
Holding current value
$48.9 Million
Previous $45.5 Million 2.68%
% of portfolio
0.15%
Previous 0.15%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $968,237 - $1.07 Million
1,788 Added 2.29%
80,035 $44.3 Million
Q1 2024

May 09, 2024

BUY
$528.82 - $599.43 $782,653 - $887,156
1,480 Added 1.93%
78,247 $45.5 Million
Q4 2023

Feb 12, 2024

BUY
$431.41 - $532.94 $1.05 Million - $1.29 Million
2,423 Added 3.26%
76,767 $40.7 Million
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $1.22 Million - $1.41 Million
-2,450 Reduced 3.19%
74,344 $37.6 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $374,735 - $435,662
-737 Reduced 0.95%
76,794 $40.1 Million
Q1 2023

May 12, 2023

SELL
$535.0 - $604.82 $1.85 Million - $2.09 Million
-3,449 Reduced 4.26%
77,531 $44.7 Million
Q4 2022

Feb 10, 2023

SELL
$484.71 - $571.37 $58.8 Million - $69.3 Million
-121,258 Reduced 59.96%
80,980 $44.6 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $23.4 Million - $27.9 Million
46,169 Added 29.58%
202,238 $103 Million
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $35.9 Million - $43.9 Million
-71,714 Reduced 31.48%
156,069 $84.8 Million
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $9.5 Million - $11.7 Million
-18,131 Reduced 7.37%
227,783 $135 Million
Q4 2021

Feb 11, 2022

BUY
$569.0 - $667.24 $91.4 Million - $107 Million
160,546 Added 188.06%
245,914 $164 Million
Q3 2021

Nov 09, 2021

BUY
$509.53 - $609.78 $11.5 Million - $13.8 Million
22,593 Added 35.99%
85,368 $48.8 Million
Q2 2021

Aug 11, 2021

SELL
$441.0 - $508.24 $359,856 - $414,723
-816 Reduced 1.28%
62,775 $31.7 Million
Q1 2021

May 11, 2021

BUY
$439.85 - $518.83 $28 Million - $33 Million
63,591 New
63,591 $29 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $18.2 Million - $24 Million
-66,235 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $14 Million - $18.6 Million
-54,716 Reduced 45.24%
66,235 $18.8 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $9.52 Million - $11.5 Million
-35,021 Reduced 22.45%
120,951 $39.3 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $4.26 Million - $4.85 Million
-15,884 Reduced 9.24%
155,972 $45.4 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $107,639 - $123,539
-418 Reduced 0.24%
171,856 $50.5 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $31.5 Million - $40.6 Million
148,474 Added 623.84%
172,274 $47.2 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $4.96 Million - $6 Million
23,800 New
23,800 $5.33 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $33.7 Million - $39.2 Million
-174,740 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$182.03 - $200.37 $11 Million - $12.1 Million
-60,294 Reduced 25.65%
174,740 $33.2 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $32 Million - $36.2 Million
-186,367 Reduced 44.23%
235,034 $44.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
421,401
421,401 $73.5 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $239B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.